首页 > 最新文献

Global health & medicine最新文献

英文 中文
HIV disease progression among heterosexually-infected individuals before the introduction of universal ART in China: A linear mixed-effects model. 中国普及抗逆转录病毒疗法前异性感染者的艾滋病进展:线性混合效应模型
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-10-31 DOI: 10.35772/ghm.2024.01030
Lin Tang, Fangfang Chen, Qian Ling, Peilong Li, Lin Ge, Chang Cai, Houlin Tang, Fan Lv, Dongmin Li

In 2016, China introduced universal antiretroviral therapy (ART) for all HIV-infected individuals regardless of CD4 cell count. However, the natural history and rate of CD4 count decline among heterosexually-infected individuals remain uncharacterized. Analyzing national surveillance data can address this gap and shed light on the pathogenesis of HIV in this population. We used a linear mixed-effects model to assess CD4 trajectory over time before ART initiation and estimated the median time from HIV seroconversion to reaching CD4 thresholds of < 500, < 350, and < 200 cell/mm3. From the Chinese HIV/AIDS Comprehensive Response Information Management System, 59,085 eligible individuals were identified, with 113 having data to estimate the date of HIV seroconversion. The linear mixed-effects models estimated an intercept of 23.64 (95% confidence interval [CI]: 22.41 to 24.87) and a slope of -1.32 (95% CI: -1.34 to -1.30) for males, and an intercept of 22.70 (95% CI: 21.00 to 24.40) and a slope of -1.29 (95% CI: -1.31 to -1.27) for females. The estimated median times from HIV seroconversion to reaching CD4 count thresholds of < 500, < 350, < 200 cells/mm3 were 0.97, 3.74, and 7.20 years for males, and 0.26, 3.09, and 6.48 years for females, respectively. Males consistently took longer to reach these CD4 count thresholds compared to females of the same age group. Older individuals (≥ 40 years) reached CD4 thresholds faster than younger individuals (15-29 years), indicating more rapid disease progression in older people living with HIV.

2016 年,中国开始对所有艾滋病病毒感染者普及抗逆转录病毒疗法(ART),无论其 CD4 细胞计数如何。然而,异性感染者的自然史和 CD4 细胞数下降率仍未得到描述。分析国家监测数据可以弥补这一不足,并揭示该人群的艾滋病发病机制。我们使用线性混合效应模型评估了开始接受抗逆转录病毒疗法前 CD4 随时间变化的轨迹,并估算了从 HIV 血清转换到达到 CD4 临界值 < 500、< 350 和 < 200 cells/mm3 的中位时间。从中国艾滋病综合防治信息管理系统中确定了 59085 名符合条件的个体,其中 113 人的数据可用于估算 HIV 血清转换日期。线性混合效应模型估计男性的截距为 23.64(95% 置信区间 [CI]:22.41 至 24.87),斜率为-1.32(95% CI:-1.34 至-1.30);女性的截距为 22.70(95% CI:21.00 至 24.40),斜率为-1.29(95% CI:-1.31 至-1.27)。从 HIV 血清转换到达到 CD4 细胞计数阈值 < 500、< 350 和 < 200 cells/mm3 的估计中位时间,男性分别为 0.97 年、3.74 年和 7.20 年,女性分别为 0.26 年、3.09 年和 6.48 年。与同年龄组的女性相比,男性达到这些 CD4 细胞数阈值所需的时间更长。老年人(≥ 40 岁)比年轻人(15-29 岁)更快达到 CD4 临界值,这表明感染艾滋病毒的老年人疾病进展更快。
{"title":"HIV disease progression among heterosexually-infected individuals before the introduction of universal ART in China: A linear mixed-effects model.","authors":"Lin Tang, Fangfang Chen, Qian Ling, Peilong Li, Lin Ge, Chang Cai, Houlin Tang, Fan Lv, Dongmin Li","doi":"10.35772/ghm.2024.01030","DOIUrl":"10.35772/ghm.2024.01030","url":null,"abstract":"<p><p>In 2016, China introduced universal antiretroviral therapy (ART) for all HIV-infected individuals regardless of CD4 cell count. However, the natural history and rate of CD4 count decline among heterosexually-infected individuals remain uncharacterized. Analyzing national surveillance data can address this gap and shed light on the pathogenesis of HIV in this population. We used a linear mixed-effects model to assess CD4 trajectory over time before ART initiation and estimated the median time from HIV seroconversion to reaching CD4 thresholds of < 500, < 350, and < 200 cell/mm<sup>3</sup>. From the Chinese HIV/AIDS Comprehensive Response Information Management System, 59,085 eligible individuals were identified, with 113 having data to estimate the date of HIV seroconversion. The linear mixed-effects models estimated an intercept of 23.64 (95% confidence interval [CI]: 22.41 to 24.87) and a slope of -1.32 (95% CI: -1.34 to -1.30) for males, and an intercept of 22.70 (95% CI: 21.00 to 24.40) and a slope of -1.29 (95% CI: -1.31 to -1.27) for females. The estimated median times from HIV seroconversion to reaching CD4 count thresholds of < 500, < 350, < 200 cells/mm<sup>3</sup> were 0.97, 3.74, and 7.20 years for males, and 0.26, 3.09, and 6.48 years for females, respectively. Males consistently took longer to reach these CD4 count thresholds compared to females of the same age group. Older individuals (≥ 40 years) reached CD4 thresholds faster than younger individuals (15-29 years), indicating more rapid disease progression in older people living with HIV.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 5","pages":"333-338"},"PeriodicalIF":1.9,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142560331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of X-ray protective goggles in mitigating eye lens radiation exposure during radiopharmaceutical handling and patient care in nuclear medicine. 评估 X 射线防护镜在核医学中处理放射性药物和护理病人时减少眼睛晶状体辐 射量的效果。
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-31 DOI: 10.35772/ghm.2024.01023
Tomoko Oikawa, Kaori Saito, Keiichi Kurihara, Daisuke Horikawa, Katsuhiko Uruno, Hironori Kajiwara, Shuhei Ohashi, Masatoshi Hotta, Naoyuki Yagi, Hideaki Kitamura, Shinichi Hasegawa, Ryogo Minamimoto

The aim of this study is to estimate eye lens exposure dose when handling radiopharmaceuticals and interacting with patients receiving radiopharmaceuticals, and to verify the usefulness of X-ray protective goggles in mitigating such radiation exposure using phantoms. To evaluate radiation exposure during the handling of radiopharmaceuticals, we employed a fluorescent glass dosimeter to measure the radiation doses associated with 99mTc, 123I, 131I, 111In, and 18F at distances of 30 cm and 60 cm, followed by calculation of the 3 mm dose equivalent rate (3DER). We then estimated the dose reduction rates for various scenarios, including the use of syringe shields and X-ray protective goggles with lead equivalences of 0.07, 0.15, 0.75, and 0.88 mmPb, as well as their combined application. X-ray protective goggles with lead equivalence of 0.75 mmPb outperformed those with 0.07 mmPb and 0.15 mmPb, for all radionuclides and at both source distances. X-ray protective goggles with 0.88 mmPb outperformed those with 0.75 mmPb during handling of 131I and 111In at a distance of 30 cm. In the remaining scenarios, X-ray protective goggles with 0.88 mmPb resulted in marginal reductions or no discernible additional effects. The overall shielding effect of X-ray protective goggles was less pronounced for 131I and 18F, but the combined use of a syringe shield with X-ray protective goggles with 0.75 or 0.88 mmPb improved the dose reduction rate for all scenarios. In simulating patient care, X-ray protective goggles with 0.88 mmPb demonstrated a dose reduction effect of approximately 50% or more. X-ray protective goggles could reduce the 3DER for the eye lens, and were more effective when combined with a syringe shield. It is valid to use a lead equivalence of 0.88 mmPb to fully harness the protective capabilities of X-ray shielding goggles when dealing with all five types of nuclides in clinical settings.

本研究的目的是估算在处理放射性药物和与接受放射性药物的患者接触时眼球镜片受到的辐射剂量,并利用模型验证 X 射线防护镜在减轻此类辐射照射方面的作用。为了评估处理放射性药物时的辐照量,我们使用荧光玻璃剂量计在 30 厘米和 60 厘米的距离测量 99mTc、123I、131I、111In 和 18F 的相关辐射剂量,然后计算 3 毫米剂量当量率 (3DER)。然后,我们估算了各种情况下的剂量减少率,包括使用注射器防护罩和铅当量为 0.07、0.15、0.75 和 0.88 mmPb 的 X 射线防护镜,以及它们的组合应用。对于所有放射性核素和两种放射源距离,铅当量为 0.75 mmPb 的 X 射线防护镜都优于铅当量为 0.07 mmPb 和 0.15 mmPb 的防护镜。在 30 厘米距离内处理 131I 和 111In 时,0.88 mmPb 的 X 射线防护镜优于 0.75 mmPb 的防护镜。在其他情况下,0.88 mmPb 的 X 射线防护镜的屏蔽效果略有降低或没有明显的额外效果。X 射线防护镜对 131I 和 18F 的整体屏蔽效果并不明显,但同时使用注射器防护罩和 0.75 或 0.88 mmPb 的 X 射线防护镜可提高所有情况下的剂量降低率。在模拟病人护理时,0.88 mmPb 的 X 射线防护镜可减少约 50% 或更多的剂量。X 射线防护镜可以减少眼睛晶状体的 3DER,与注射器防护罩结合使用效果更好。在临床环境中处理所有五种核素时,使用 0.88 mmPb 铅当量来充分利用 X 射线防护镜的防护能力是有效的。
{"title":"Evaluation of X-ray protective goggles in mitigating eye lens radiation exposure during radiopharmaceutical handling and patient care in nuclear medicine.","authors":"Tomoko Oikawa, Kaori Saito, Keiichi Kurihara, Daisuke Horikawa, Katsuhiko Uruno, Hironori Kajiwara, Shuhei Ohashi, Masatoshi Hotta, Naoyuki Yagi, Hideaki Kitamura, Shinichi Hasegawa, Ryogo Minamimoto","doi":"10.35772/ghm.2024.01023","DOIUrl":"10.35772/ghm.2024.01023","url":null,"abstract":"<p><p>The aim of this study is to estimate eye lens exposure dose when handling radiopharmaceuticals and interacting with patients receiving radiopharmaceuticals, and to verify the usefulness of X-ray protective goggles in mitigating such radiation exposure using phantoms. To evaluate radiation exposure during the handling of radiopharmaceuticals, we employed a fluorescent glass dosimeter to measure the radiation doses associated with <sup>99m</sup>Tc, <sup>123</sup>I, <sup>131</sup>I, <sup>111</sup>In, and <sup>18</sup>F at distances of 30 cm and 60 cm, followed by calculation of the 3 mm dose equivalent rate (3DER). We then estimated the dose reduction rates for various scenarios, including the use of syringe shields and X-ray protective goggles with lead equivalences of 0.07, 0.15, 0.75, and 0.88 mmPb, as well as their combined application. X-ray protective goggles with lead equivalence of 0.75 mmPb outperformed those with 0.07 mmPb and 0.15 mmPb, for all radionuclides and at both source distances. X-ray protective goggles with 0.88 mmPb outperformed those with 0.75 mmPb during handling of <sup>131</sup>I and <sup>111</sup>In at a distance of 30 cm. In the remaining scenarios, X-ray protective goggles with 0.88 mmPb resulted in marginal reductions or no discernible additional effects. The overall shielding effect of X-ray protective goggles was less pronounced for 131I and 18F, but the combined use of a syringe shield with X-ray protective goggles with 0.75 or 0.88 mmPb improved the dose reduction rate for all scenarios. In simulating patient care, X-ray protective goggles with 0.88 mmPb demonstrated a dose reduction effect of approximately 50% or more. X-ray protective goggles could reduce the 3DER for the eye lens, and were more effective when combined with a syringe shield. It is valid to use a lead equivalence of 0.88 mmPb to fully harness the protective capabilities of X-ray shielding goggles when dealing with all five types of nuclides in clinical settings.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 4","pages":"244-250"},"PeriodicalIF":1.9,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Employment status of older nursing staff aged 55 years and older in care facilities: A nationwide cross-sectional study in Japan. 护理机构中 55 岁及以上老年护理人员的就业状况:日本全国横断面研究。
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-31 DOI: 10.35772/ghm.2024.01026
Ayako Furukawa, Masayo Kashiwagi, Noriko Morioka

An aging nursing workforce requires addressing shortages due to retirement. This nationwide descriptive cross-sectional study in Japan clarified the employment status of older nursing staff aged ≥ 55 years by facility type during January-March 2022. Questionnaires were sent to 8,000 nursing directors, with 1,658 valid responses (response rate: 20.7%). Descriptive statistics and Kruskal-Wallis or χ2 tests analyzed inter-facility differences. A violin plot depicted the proportion of older nursing staff across facilities by age group, and generalized estimating equation (GEE) models examined associated factors at the facility level. Older nursing staff's distribution differed significantly across age groups (p < 0.01), from 0% to 100% within the same facility type. Some facilities had high percentages of staff working beyond retirement age. GEE results showed higher percentages of full-time employees and nurses were negatively associated with the percentage of older nursing staff across most facility types (p < 0.05). For those aged ≥ 65 years, the total population was positively associated with employment in bedded clinics (coef. = 0.07, 95% CI: 0.01 to 0.14, p = 0.03), but negatively associated with the total population (coef. = -0.06, 95% CI: -0.10 to -0.01, p = 0.02) and percentage of the population aged ≥ 65 (coef. = -0.76, 95% CI: -1.43 to -0.08, p = 0.03) in long-term care insurance facilities. Working conditions and environments should be improvement to potentially retain older nursing staff. Job seekers should be matched with managers' needs in facilities with a higher proportion of older nursing staff to ensure a sustainable workforce.

随着护理人员队伍的老龄化,需要解决因退休而造成的人员短缺问题。这项在日本全国范围内进行的横断面描述性研究,按机构类型明确了 2022 年 1 月至 3 月期间年龄≥ 55 岁的老年护理人员的就业状况。共向 8000 名护理主任发送了调查问卷,收到 1658 份有效回复(回复率:20.7%)。描述性统计和 Kruskal-Wallis 或 χ2 检验分析了机构间的差异。小提琴图按年龄组描述了各机构中老年护理人员的比例,广义估计方程(GEE)模型研究了机构层面的相关因素。不同年龄组的老年护理人员分布差异显著(p < 0.01),在同一设施类型中,老年护理人员的比例从 0% 到 100% 不等。一些机构中超过退休年龄的员工比例较高。GEE 结果显示,在大多数设施类型中,全职员工和护士的比例较高与老年护理人员的比例呈负相关(p < 0.05)。对于年龄≥65 岁的人员,总人口与床位诊所的就业率呈正相关(系数 = 0.07,95% CI:0.01 至 0.14,p = 0.03),但与长期护理保险机构的总人口(系数 = -0.06,95% CI:-0.10 至 -0.01,p = 0.02)和年龄≥65 岁的人口比例(系数 = -0.76,95% CI:-1.43 至 -0.08,p = 0.03)呈负相关。应改善工作条件和环境,以留住老年护理人员。在老年护理人员比例较高的机构中,求职者应与管理人员的需求相匹配,以确保员工队伍的可持续发展。
{"title":"Employment status of older nursing staff aged 55 years and older in care facilities: A nationwide cross-sectional study in Japan.","authors":"Ayako Furukawa, Masayo Kashiwagi, Noriko Morioka","doi":"10.35772/ghm.2024.01026","DOIUrl":"10.35772/ghm.2024.01026","url":null,"abstract":"<p><p>An aging nursing workforce requires addressing shortages due to retirement. This nationwide descriptive cross-sectional study in Japan clarified the employment status of older nursing staff aged ≥ 55 years by facility type during January-March 2022. Questionnaires were sent to 8,000 nursing directors, with 1,658 valid responses (response rate: 20.7%). Descriptive statistics and Kruskal-Wallis or χ2 tests analyzed inter-facility differences. A violin plot depicted the proportion of older nursing staff across facilities by age group, and generalized estimating equation (GEE) models examined associated factors at the facility level. Older nursing staff's distribution differed significantly across age groups (<i>p</i> < 0.01), from 0% to 100% within the same facility type. Some facilities had high percentages of staff working beyond retirement age. GEE results showed higher percentages of full-time employees and nurses were negatively associated with the percentage of older nursing staff across most facility types (<i>p</i> < 0.05). For those aged ≥ 65 years, the total population was positively associated with employment in bedded clinics (coef. = 0.07, 95% CI: 0.01 to 0.14, <i>p</i> = 0.03), but negatively associated with the total population (coef. = -0.06, 95% CI: -0.10 to -0.01, <i>p</i> = 0.02) and percentage of the population aged ≥ 65 (coef. = -0.76, 95% CI: -1.43 to -0.08, <i>p</i> = 0.03) in long-term care insurance facilities. Working conditions and environments should be improvement to potentially retain older nursing staff. Job seekers should be matched with managers' needs in facilities with a higher proportion of older nursing staff to ensure a sustainable workforce.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 4","pages":"225-235"},"PeriodicalIF":1.9,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the daily life needs of older public assistance recipient subgroups in Japan: A qualitative study. 了解日本老年公共援助受助者亚群的日常生活需求:定性研究。
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-31 DOI: 10.35772/ghm.2024.01029
Keiko Ueno, Daisuke Nishioka, Junko Saito, Shiho Kino, Naoki Kondo

Transition from individual-level treatment to social-level intervention should be made to improve peoples daily living conditions for reducing health inequality, which is a major global public health concern. Older public assistance recipients in Japan are socially vulnerable and require healthcare, long-term care, daily living, and social care support. Understanding the diverse daily living needs among public assistance recipient subgroups would prompt the development of novel support measures in the welfare sector. Therefore, this study aimed to understand the daily life needs of older recipient subgroups (segments) created quantitatively in our previous study. We interviewed four caseworkers at municipal welfare offices in 2021; the interview data were analyzed using a qualitative descriptive method to describe the daily life needs of the five older recipient segments for each sex. Five themes of daily life needs were demonstrated: i) housing, ii) financial, iii) welfare service, iv) healthcare, and v) no daily life needs. Consequently, we identified the daily life needs of some older recipient segments, indicating the necessity for support interventions. Future research would help interview other professionals from various backgrounds to further understand the daily life needs of older recipient segments.

应从个人层面的治疗过渡到社会层面的干预,以改善人们的日常生活条件,减少健康不平等现象,这是全球公共卫生关注的一个主要问题。日本接受公共援助的老年人是社会弱势群体,需要医疗保健、长期护理、日常生活和社会关怀支持。了解公共援助受助者亚群的不同日常生活需求将有助于福利部门制定新的支持措施。因此,本研究旨在了解我们之前研究中定量创建的老年受助者亚群(群体)的日常生活需求。我们在 2021 年采访了市福利办公室的四名个案工作者,并采用定性描述法对访谈数据进行分析,以描述每个性别的五个老年受助人群体的日常生活需求。结果显示了日常生活需求的五个主题:i) 住房;ii) 经济;iii) 福利服务;iv) 医疗保健;v) 无日常生活需求。因此,我们确定了一些老年受助者群体的日常生活需求,表明有必要采取支持干预措施。未来的研究将有助于访问来自不同背景的其他专业人士,以进一步了解受助老年人群的日常生活需求。
{"title":"Understanding the daily life needs of older public assistance recipient subgroups in Japan: A qualitative study.","authors":"Keiko Ueno, Daisuke Nishioka, Junko Saito, Shiho Kino, Naoki Kondo","doi":"10.35772/ghm.2024.01029","DOIUrl":"10.35772/ghm.2024.01029","url":null,"abstract":"<p><p>Transition from individual-level treatment to social-level intervention should be made to improve peoples daily living conditions for reducing health inequality, which is a major global public health concern. Older public assistance recipients in Japan are socially vulnerable and require healthcare, long-term care, daily living, and social care support. Understanding the diverse daily living needs among public assistance recipient subgroups would prompt the development of novel support measures in the welfare sector. Therefore, this study aimed to understand the daily life needs of older recipient subgroups (segments) created quantitatively in our previous study. We interviewed four caseworkers at municipal welfare offices in 2021; the interview data were analyzed using a qualitative descriptive method to describe the daily life needs of the five older recipient segments for each sex. Five themes of daily life needs were demonstrated: <i>i</i>) housing, <i>ii</i>) financial, <i>iii</i>) welfare service, <i>iv</i>) healthcare, and <i>v</i>) no daily life needs. Consequently, we identified the daily life needs of some older recipient segments, indicating the necessity for support interventions. Future research would help interview other professionals from various backgrounds to further understand the daily life needs of older recipient segments.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 4","pages":"259-263"},"PeriodicalIF":1.9,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective single institutional analysis of outpatient chemotherapy in patients with cancer during the COVID-19 pandemic. COVID-19 大流行期间癌症患者门诊化疗的单一机构回顾性分析。
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-31 DOI: 10.35772/ghm.2023.01134
Yumiko Shimanuki, Akihiko Shimomura, Chiaki Ogawa, Masato Komuro, Hiroyuki Terakado, Takahiro Nishimura, Chikako Shimizu

Providing treatment to patients with cancer, even during the coronavirus disease (COVID-19) pandemic, is essential. In collaboration with infectious disease specialists, we established guidelines for the management of patients with cancer receiving ambulatory treatment during the pandemic on April 8, 2020. This study examined the practice and management of ambulatory chemotherapy under emergency conditions. Following the guidelines, our Breast and Medical oncology department developed a chemotherapy strategy for the phases. Additionally, to distinguish fever during chemotherapy, we developed a flow chart for fever. As part of a fact-finding survey, the status of outpatient chemotherapy was investigated: (1) whether there was any change in the number of chemotherapies before and after the declaration of a state of emergency by the Tokyo Metropolitan Government and (2) the frequency and severity of febrile neutropenia (FN) cases. Compared to before the first declaration of the state of emergency, the number of chemotherapies decreased except after the declaration, but no decrease was observed during the rest of the period; no difference was observed in the frequency or severity of FN outbreaks or in the use of pegfilgrastim for primary prevention before and after the epidemic. With appropriate treatment guidelines, routine chemotherapy can be performed in an outpatient setting during an outbreak.

即使在冠状病毒病(COVID-19)大流行期间,也必须为癌症患者提供治疗。我们与传染病专家合作,于 2020 年 4 月 8 日制定了在大流行期间接受非住院治疗的癌症患者的管理指南。这项研究考察了紧急情况下非住院化疗的实践和管理情况。根据指南,我们的乳腺肿瘤内科制定了阶段性化疗策略。此外,为了区分化疗期间的发热,我们还制定了发热流程图。作为实况调查的一部分,我们对门诊化疗的状况进行了调查:(1) 东京都政府宣布进入紧急状态前后化疗次数是否有变化;(2) 发热性中性粒细胞减少症(FN)病例的频率和严重程度。与首次宣布紧急状态之前相比,化疗次数除在宣布紧急状态之后有所减少外,其余时间均没有减少;在疫情爆发前后,发热性中性粒细胞减少症的发病频率和严重程度以及使用 pegfilgrastim 进行一级预防的情况均无差异。有了适当的治疗指南,在疫情爆发期间可以在门诊环境中进行常规化疗。
{"title":"A retrospective single institutional analysis of outpatient chemotherapy in patients with cancer during the COVID-19 pandemic.","authors":"Yumiko Shimanuki, Akihiko Shimomura, Chiaki Ogawa, Masato Komuro, Hiroyuki Terakado, Takahiro Nishimura, Chikako Shimizu","doi":"10.35772/ghm.2023.01134","DOIUrl":"10.35772/ghm.2023.01134","url":null,"abstract":"<p><p>Providing treatment to patients with cancer, even during the coronavirus disease (COVID-19) pandemic, is essential. In collaboration with infectious disease specialists, we established guidelines for the management of patients with cancer receiving ambulatory treatment during the pandemic on April 8, 2020. This study examined the practice and management of ambulatory chemotherapy under emergency conditions. Following the guidelines, our Breast and Medical oncology department developed a chemotherapy strategy for the phases. Additionally, to distinguish fever during chemotherapy, we developed a flow chart for fever. As part of a fact-finding survey, the status of outpatient chemotherapy was investigated: (1) whether there was any change in the number of chemotherapies before and after the declaration of a state of emergency by the Tokyo Metropolitan Government and (2) the frequency and severity of febrile neutropenia (FN) cases. Compared to before the first declaration of the state of emergency, the number of chemotherapies decreased except after the declaration, but no decrease was observed during the rest of the period; no difference was observed in the frequency or severity of FN outbreaks or in the use of pegfilgrastim for primary prevention before and after the epidemic. With appropriate treatment guidelines, routine chemotherapy can be performed in an outpatient setting during an outbreak.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 4","pages":"268-272"},"PeriodicalIF":1.9,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between the paracaval branches of the caudate lobe and the three major hepatic veins in liver casts: Locating the cranial boundary of the caudate lobe. 肝铸模中尾状叶腔旁分支与三条主要肝静脉之间的联系:定位尾状叶的颅骨边界。
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-31 DOI: 10.35772/ghm.2024.01012
Masamitsu Kumon, Tsutomu Namikawa, Nobuyuki Takemura, Masaharu Kogure, Yoshihiro Sakamoto

According to Couinaud's definition, the cranial boundary of the caudate lobe is delineated by the three major hepatic veins. However, many branches of the caudate lobe go through the ceiling that is composed of these hepatic veins. The cranial boundary of the caudate lobe should be determined by employing the portal segmentation. We conducted a study based on the dissection of 37 colored resin liver casts to reveal the caudate branches of the liver. The paracaval portal vein branches (PCPvs) were defined as cranial portal branches from the main trunk or first-order branch of the portal vein distributed in front of the inferior vena cava, according to Kumon's classification. The PCVs were traced to reveal the cranial boundary of the caudate lobe. Results showed that in 18 cases (49%), the PCPvs reached the liver surface through the gap between the right and middle hepatic veins (type RM, n = 11), between the tiny branches of the middle hepatic vein (type M, n = 4), and between the middle and left hepatic veins (type ML, n = 3). The PCPvs did not reach the liver surface in 19 cases (type 0). No PCPvs reached the hepatic surface behind the right hepatic vein. Half of the PCPvs in the liver reached the hepatic surface beyond the boundary composed of the three major hepatic veins. Recognition of the PCPvs in the liver is indispensable to perform anatomically precise liver resections involving the major hepatic veins.

根据库诺(Couinaud)的定义,尾状叶的颅界由三条主要肝静脉划定。然而,尾状叶的许多分支都穿过由这些肝静脉组成的天花板。尾状叶的头端边界应通过门静脉分割来确定。我们对 37 个彩色树脂肝脏铸模进行了解剖研究,以揭示肝脏尾状叶的分支。根据 Kumon 的分类,腔旁门静脉分支(PCPvs)是指分布在下腔静脉前方的门静脉主干或一阶分支的头端门静脉分支。对 PCV 进行追踪,以揭示尾状叶的颅界。结果显示,18 个病例(49%)的 PCPvs 通过肝右静脉和肝中静脉之间的间隙(RM 型,n = 11)、肝中静脉细小分支之间的间隙(M 型,n = 4)以及肝中静脉和肝左静脉之间的间隙(ML 型,n = 3)到达肝脏表面。有 19 例 PCPvs 未到达肝脏表面(0 型)。没有 PCPvs 到达右肝静脉后方的肝表面。肝脏中的 PCPvs 有一半到达了由三条主要肝静脉组成的边界以外的肝脏表面。要对涉及肝主静脉的肝脏进行解剖学上精确的切除,识别肝脏中的 PCPvs 是必不可少的。
{"title":"Association between the paracaval branches of the caudate lobe and the three major hepatic veins in liver casts: Locating the cranial boundary of the caudate lobe.","authors":"Masamitsu Kumon, Tsutomu Namikawa, Nobuyuki Takemura, Masaharu Kogure, Yoshihiro Sakamoto","doi":"10.35772/ghm.2024.01012","DOIUrl":"10.35772/ghm.2024.01012","url":null,"abstract":"<p><p>According to Couinaud's definition, the cranial boundary of the caudate lobe is delineated by the three major hepatic veins. However, many branches of the caudate lobe go through the ceiling that is composed of these hepatic veins. The cranial boundary of the caudate lobe should be determined by employing the portal segmentation. We conducted a study based on the dissection of 37 colored resin liver casts to reveal the caudate branches of the liver. The paracaval portal vein branches (PCPvs) were defined as cranial portal branches from the main trunk or first-order branch of the portal vein distributed in front of the inferior vena cava, according to Kumon's classification. The PCVs were traced to reveal the cranial boundary of the caudate lobe. Results showed that in 18 cases (49%), the PCPvs reached the liver surface through the gap between the right and middle hepatic veins (type RM, <i>n</i> = 11), between the tiny branches of the middle hepatic vein (type M, <i>n</i> = 4), and between the middle and left hepatic veins (type ML, <i>n</i> = 3). The PCPvs did not reach the liver surface in 19 cases (type 0). No PCPvs reached the hepatic surface behind the right hepatic vein. Half of the PCPvs in the liver reached the hepatic surface beyond the boundary composed of the three major hepatic veins. Recognition of the PCPvs in the liver is indispensable to perform anatomically precise liver resections involving the major hepatic veins.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 4","pages":"273-276"},"PeriodicalIF":1.9,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening health systems during non-pandemic period: Toward universal health coverage in the pandemic agreement. 在非大流行病期间加强卫生系统:在大流行协议中实现全民医保。
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-31 DOI: 10.35772/ghm.2024.01035
Yuta Yokobori, Ikuma Nozaki, Masahiko Hachiya, Masami Fujita, Yuriko Egami, Shinsuke Miyano, Mari Nagai, Kenichi Komada, Masataro Norizuki, Yasunori Ichimura, Motoyuki Tsuboi, Nobuyuki Kawachi, Shunji Takakura

Reflecting the experiences of the COVID-19 pandemic, the global response was reviewed by the Independent Review Panel for Pandemic Preparedness and Response. Based on the panel reports, the World Health Organization (WHO) member states decided to establish the intergovernmental negotiating body for drafting a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response, aiming for approval at the 77th World Health Assembly in 2024 (May 27- June 1). Amidst this process, the National Center for Global Health and Medicine, Japan (NCGM), as a global health organization focusing on health system strengthening in low- and middle-income countries, from the perspective of Universal Health Coverage (UHC), provided technical inputs to the representatives of the Japanese government. This paper summarizes crucial aspects of the NCGM inputs, including maintaining essential health services delivery during a pandemic, responding to evolving demand of health workforce, and ensuring the equitable distribution of pandemic products. These aspects can contribute to not only strengthening health crisis response and preparedness, but also achieving UHC. Therefore, the concerted efforts focusing on UHC and health crisis could yield synergistic effects. In addition, another aspect stresses the importance of social protection systems beyond health sector to reach vulnerable populations experiencing hardships during the COVID-19 pandemic. Since the whole-of-government approach including social policies is covered in the draft pandemic agreement, it is hoped that the upcoming pandemic agreement will trigger each member state to expand the scope of health crisis management beyond the health sector.

根据 COVID-19 大流行病的经验,大流行病防备和应对独立审查小组审查了全球应对措施。根据小组报告,世界卫生组织(WHO)成员国决定成立一个政府间谈判机构,负责起草一份关于大流行病预防、准备和应对的世卫组织公约、协定或其他国际文书,争取在 2024 年(5 月 27 日至 6 月 1 日)第 77 届世界卫生大会上获得批准。在这一过程中,日本国家全球卫生与医学中心(NCGM)作为一个全球卫生组织,从全民健康覆盖(UHC)的角度出发,致力于加强中低收入国家的卫生系统,为日本政府代表提供了技术投入。本文总结了 NCGM 投入的关键方面,包括在大流行期间维持基本医疗服务的提供、应对不断变化的医疗卫生劳动力需求以及确保大流行产品的公平分配。这些方面不仅有助于加强卫生危机应对和准备工作,也有助于实现全民健康。因此,以全民保健和卫生危机为重点的协同努力可以产生协同效应。此外,另一个方面强调了在 COVID-19 大流行期间,卫生部门以外的社会保护系统对于帮助遭遇困难的弱势群体的重要性。由于大流行病协定草案涵盖了包括社会政策在内的整体政府方法,我们希望即将达成的大流行病协定将促使每个成员国将卫生危机管理的范围扩大到卫生部门之外。
{"title":"Strengthening health systems during non-pandemic period: Toward universal health coverage in the pandemic agreement.","authors":"Yuta Yokobori, Ikuma Nozaki, Masahiko Hachiya, Masami Fujita, Yuriko Egami, Shinsuke Miyano, Mari Nagai, Kenichi Komada, Masataro Norizuki, Yasunori Ichimura, Motoyuki Tsuboi, Nobuyuki Kawachi, Shunji Takakura","doi":"10.35772/ghm.2024.01035","DOIUrl":"10.35772/ghm.2024.01035","url":null,"abstract":"<p><p>Reflecting the experiences of the COVID-19 pandemic, the global response was reviewed by the Independent Review Panel for Pandemic Preparedness and Response. Based on the panel reports, the World Health Organization (WHO) member states decided to establish the intergovernmental negotiating body for drafting a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response, aiming for approval at the 77<sup>th</sup> World Health Assembly in 2024 (May 27- June 1). Amidst this process, the National Center for Global Health and Medicine, Japan (NCGM), as a global health organization focusing on health system strengthening in low- and middle-income countries, from the perspective of Universal Health Coverage (UHC), provided technical inputs to the representatives of the Japanese government. This paper summarizes crucial aspects of the NCGM inputs, including maintaining essential health services delivery during a pandemic, responding to evolving demand of health workforce, and ensuring the equitable distribution of pandemic products. These aspects can contribute to not only strengthening health crisis response and preparedness, but also achieving UHC. Therefore, the concerted efforts focusing on UHC and health crisis could yield synergistic effects. In addition, another aspect stresses the importance of social protection systems beyond health sector to reach vulnerable populations experiencing hardships during the COVID-19 pandemic. Since the whole-of-government approach including social policies is covered in the draft pandemic agreement, it is hoped that the upcoming pandemic agreement will trigger each member state to expand the scope of health crisis management beyond the health sector.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 4","pages":"251-255"},"PeriodicalIF":1.9,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The future of inbound medical care as gauged from the foreigners undergoing complete medical examinations in Japan. 从在日本接受全面体检的外国人看入境医疗的未来。
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-31 DOI: 10.35772/ghm.2023.01126
Jun Lu, Sachiko Kubo, Makiko Hashimoto, Yuko Hayashi, Erika Masuda, Hiroshi Kajio, Masayuki Shimoda

Complete medical examinations are a system of preventive medicine unique to Japan. In recent years, Japanese and foreigners have been aware of complete medical examinations. However, the extent to which this concept of comprehensive medical checkup is recognized in different counties is unknown. The National Center for Global Health and Medicine (NCGM) is a facility that has been performing complete medical examinations on inbound visitors since May 2016, and more than 3,500 inbound visitors have been received to date. Based on this track record, the current study analyzed trends in foreigners' demand for medical checkups in Japan. From August 2020 to July 2023, 471 foreign residents in Japan from 22 countries were received. A certain proportion of examinees (approximately 30%) underwent examinations multiple times at a frequency of once a year. In addition, inbound medical visitors resumed starting in January 2023, and 158 inbound examinees were received. Of these, 15.2% of examinees had undergone a complete medical examination at the NCGM before the COVID-19 pandemic. This suggests that inbound medical visitors and foreign residents may regularly undergo complete medical examinations. In order to continue to meet this demand, Japanese medical facilities should enhance their system for receiving such examinees.

全面体检是日本特有的预防医学体系。近年来,日本人和外国人都有了全面体检的意识。然而,这种全面体检的概念在不同国家的认可程度却不得而知。国立国际健康医疗中心(National Center for Global Health and Medicine,NCGM)是一家自 2016 年 5 月起为入境游客进行全面体检的机构,迄今已接待了 3500 多名入境游客。基于这一业绩,本次研究分析了外国人在日本的体检需求趋势。从 2020 年 8 月到 2023 年 7 月,共接待了来自 22 个国家的 471 名在日外国人。一定比例的受检者(约 30%)以每年一次的频率接受了多次检查。此外,从 2023 年 1 月起,入境医疗访问者开始恢复,共接待了 158 名入境受检者。其中,15.2%的受检者在COVID-19大流行之前曾在NCGM接受过全面体检。这表明,入境医疗访问者和外国居民可能会定期接受全面体检。为了继续满足这一需求,日本的医疗机构应加强接待这类受检者的系统。
{"title":"The future of inbound medical care as gauged from the foreigners undergoing complete medical examinations in Japan.","authors":"Jun Lu, Sachiko Kubo, Makiko Hashimoto, Yuko Hayashi, Erika Masuda, Hiroshi Kajio, Masayuki Shimoda","doi":"10.35772/ghm.2023.01126","DOIUrl":"10.35772/ghm.2023.01126","url":null,"abstract":"<p><p>Complete medical examinations are a system of preventive medicine unique to Japan. In recent years, Japanese and foreigners have been aware of complete medical examinations. However, the extent to which this concept of comprehensive medical checkup is recognized in different counties is unknown. The National Center for Global Health and Medicine (NCGM) is a facility that has been performing complete medical examinations on inbound visitors since May 2016, and more than 3,500 inbound visitors have been received to date. Based on this track record, the current study analyzed trends in foreigners' demand for medical checkups in Japan. From August 2020 to July 2023, 471 foreign residents in Japan from 22 countries were received. A certain proportion of examinees (approximately 30%) underwent examinations multiple times at a frequency of once a year. In addition, inbound medical visitors resumed starting in January 2023, and 158 inbound examinees were received. Of these, 15.2% of examinees had undergone a complete medical examination at the NCGM before the COVID-19 pandemic. This suggests that inbound medical visitors and foreign residents may regularly undergo complete medical examinations. In order to continue to meet this demand, Japanese medical facilities should enhance their system for receiving such examinees.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 4","pages":"256-258"},"PeriodicalIF":1.9,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350358/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Travel-associated sexually transmitted infections in Japan: An observational study using imported infectious disease registry data. 日本与旅行有关的性传播感染:利用输入性传染病登记数据进行观察研究。
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-31 DOI: 10.35772/ghm.2023.01129
Keiji Konishi, Satoshi Kutsuna, Kei Yamamoto, Hidetoshi Nomoto, Michinori Shirano, Masaya Yamato, Yukihiro Yoshimura, Naoya Sakamoto, Atsushi Nagasaka, Norio Ohmagari

International travel is a risk factor for acquiring sexually transmitted infections (STIs) owing to factors such as increased sexual opportunities, a sense of freedom, and the allure of the sex industry. We investigated the incidence of travel-associated STIs in Japan using data from the Japan Registry for Infectious Diseases from Abroad (J-RIDA) reported by 17 participating medical institutions between October 2017 and December 2022. Data were collected on the patients' age, sex, nationality, chief complaint, whether they had visited a travel clinic before travel, travel history, and final diagnosis. Of 4545 cases of travel-associated illness reported, 52 (1.1%) were STIs. Most patients with STIs were male (81%) with a median age of 31 years. HIV (17%), genital herpes (13%), syphilis (13%), and gonorrhea (12%) were the most frequently reported STIs. Only one patient had visited a travel clinic before travel. Promoting awareness and vaccination is crucial for preventing travel-associated STIs.

由于性机会增多、自由感和性产业的诱惑等因素,国际旅行是感染性传播疾病(STI)的一个风险因素。我们利用 17 家参与医疗机构在 2017 年 10 月至 2022 年 12 月期间报告的日本国外传染病登记(J-RIDA)数据,调查了日本旅行相关性传播疾病的发病率。收集的数据包括患者的年龄、性别、国籍、主诉、旅行前是否去过旅行诊所、旅行史和最终诊断。在报告的 4545 例旅行相关疾病中,有 52 例(1.1%)是性传播疾病。大多数性传播感染患者为男性(81%),中位年龄为 31 岁。艾滋病病毒(17%)、生殖器疱疹(13%)、梅毒(13%)和淋病(12%)是最常报告的性传播疾病。只有一名患者在旅行前去过旅行诊所。提高认识和接种疫苗对于预防旅行相关性传播疾病至关重要。
{"title":"Travel-associated sexually transmitted infections in Japan: An observational study using imported infectious disease registry data.","authors":"Keiji Konishi, Satoshi Kutsuna, Kei Yamamoto, Hidetoshi Nomoto, Michinori Shirano, Masaya Yamato, Yukihiro Yoshimura, Naoya Sakamoto, Atsushi Nagasaka, Norio Ohmagari","doi":"10.35772/ghm.2023.01129","DOIUrl":"10.35772/ghm.2023.01129","url":null,"abstract":"<p><p>International travel is a risk factor for acquiring sexually transmitted infections (STIs) owing to factors such as increased sexual opportunities, a sense of freedom, and the allure of the sex industry. We investigated the incidence of travel-associated STIs in Japan using data from the Japan Registry for Infectious Diseases from Abroad (J-RIDA) reported by 17 participating medical institutions between October 2017 and December 2022. Data were collected on the patients' age, sex, nationality, chief complaint, whether they had visited a travel clinic before travel, travel history, and final diagnosis. Of 4545 cases of travel-associated illness reported, 52 (1.1%) were STIs. Most patients with STIs were male (81%) with a median age of 31 years. HIV (17%), genital herpes (13%), syphilis (13%), and gonorrhea (12%) were the most frequently reported STIs. Only one patient had visited a travel clinic before travel. Promoting awareness and vaccination is crucial for preventing travel-associated STIs.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 4","pages":"264-267"},"PeriodicalIF":1.9,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of low-frequency ultrasound combined with microbubbles on breast cancer xenografts in nude mice. 低频超声结合微气泡对裸鼠乳腺癌异种移植物的影响
IF 1.9 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-31 DOI: 10.35772/ghm.2024.01037
Xiaoli Peng, Lisha Li, Yingchun Liu, Yuqing Guo, Yun Pang, Shengnan Ding, Jing Zhou, Ling Wang, Lin Chen

The aim of this study was to explore the effects of low-frequency ultrasound (US) combined with microbubbles (MBs) on breast cancer xenografts and explain its underlying mechanisms. A total of 20 xenografted nude mice were randomly divided into four groups: a group treated with US plus MBs (the US + MBs group), a group treated with US alone (the US group), a group treated with MBs alone (the MBs group), and a control group. In different groups, mice were treated with different US and injection regimens on an alternate day, three times in total. Histological changes, apoptosis of cells, microvascular changes, and the apoptosis index (AI) and microvascular density (MVD) of the breast cancer xenograft were analyzed after the mice were sacrificed. Results indicated that the tumor volume in the US + MBs group was smaller than that in the other three groups (p < 0.001 for all). The rate of tumor growth inhibition in the US + MBs group was significantly higher than that in the US and MBs groups (p < 0.001 for both). There were no significant differences in histological changes among the four groups. However, the AI was higher in the US + MBs group than that in the other three groups while the MVD was lower (p < 0.001 for all). All in all, low-frequency US combined with MBs can effectively slow down the growth of breast cancer in nude mice. In summary, low-frequency US combined with MBs has a significant effect on breast cancer treatment. Cavitation, thermal effects, and mechanical effects all play a vital role in the inhibition of tumor growth.

本研究旨在探讨低频超声(US)与微气泡(MBs)相结合对乳腺癌异种移植的影响,并解释其潜在机制。研究人员将 20 只异种移植裸鼠随机分为四组:US 加 MBs 治疗组(US + MBs 组)、单用 US 治疗组(US 组)、单用 MBs 治疗组(MBs 组)和对照组。在不同的组别中,小鼠隔天接受不同的 US 和注射治疗,共三次。小鼠处死后,对组织学变化、细胞凋亡、微血管变化、乳腺癌异种移植的凋亡指数(AI)和微血管密度(MVD)进行分析。结果表明,US + MBs 组的肿瘤体积小于其他三组(P < 0.001)。US + MBs 组的肿瘤生长抑制率明显高于 US 组和 MBs 组(两组均为 p <0.001)。四组的组织学变化无明显差异。然而,US + MBs 组的 AI 高于其他三组,而 MVD 低于 US + MBs 组(P < 0.001)。总而言之,低频 US 联合 MBs 能有效减缓裸鼠乳腺癌的生长。总之,低频 US 与 MBs 结合在一起对乳腺癌治疗有显著效果。空化效应、热效应和机械效应在抑制肿瘤生长方面都发挥了重要作用。
{"title":"Effects of low-frequency ultrasound combined with microbubbles on breast cancer xenografts in nude mice.","authors":"Xiaoli Peng, Lisha Li, Yingchun Liu, Yuqing Guo, Yun Pang, Shengnan Ding, Jing Zhou, Ling Wang, Lin Chen","doi":"10.35772/ghm.2024.01037","DOIUrl":"10.35772/ghm.2024.01037","url":null,"abstract":"<p><p>The aim of this study was to explore the effects of low-frequency ultrasound (US) combined with microbubbles (MBs) on breast cancer xenografts and explain its underlying mechanisms. A total of 20 xenografted nude mice were randomly divided into four groups: a group treated with US plus MBs (the US + MBs group), a group treated with US alone (the US group), a group treated with MBs alone (the MBs group), and a control group. In different groups, mice were treated with different US and injection regimens on an alternate day, three times in total. Histological changes, apoptosis of cells, microvascular changes, and the apoptosis index (AI) and microvascular density (MVD) of the breast cancer xenograft were analyzed after the mice were sacrificed. Results indicated that the tumor volume in the US + MBs group was smaller than that in the other three groups (<i>p</i> < 0.001 for all). The rate of tumor growth inhibition in the US + MBs group was significantly higher than that in the US and MBs groups (<i>p</i> < 0.001 for both). There were no significant differences in histological changes among the four groups. However, the AI was higher in the US + MBs group than that in the other three groups while the MVD was lower (<i>p</i> < 0.001 for all). All in all, low-frequency US combined with MBs can effectively slow down the growth of breast cancer in nude mice. In summary, low-frequency US combined with MBs has a significant effect on breast cancer treatment. Cavitation, thermal effects, and mechanical effects all play a vital role in the inhibition of tumor growth.</p>","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 4","pages":"236-243"},"PeriodicalIF":1.9,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Global health & medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1